Article
Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.
Journal of inherited metabolic disease - 1 Jan 2005
Browning M F, Larson C, Strauss A, Marsden D L
Abstract excerpt
We report two infants identified by tandem mass spectrometry (MS/MS) of neonatal blood spot acylcarnitines and confirmed by molecular genetic analysis to have long-chain fatty acid oxidation defects. In both cases, acylcarnitine concentrations in confirmatory plasma samples were normal. None the less, molecular testing identified trifunctional protein (TFP) deficiency (McKusick 600890) and very long-chain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
